Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Vascular Health and Risk Management|May 6, 2026
The Association of Remnant Cholesterol with Obstructive Sleep Apnea and Coronary Heart Disease: A Cross-Sectional StudyTiantian Wen, Bo He, Miaomiao Ma, et al.European Journal of Drug Metabolism and Pharmacokinetics|August 1, 2023
Preclinical Pharmacokinetics and in vitro Metabolism of FHND5071, a Novel Selective RET Kinase InhibitorYiran Han, Tiantian Wen, Jia Wang, et al.Bioorganic & Medicinal Chemistry|October 13, 2022
Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancerXueyuan Wang, Tiantian Wen, Hang Miao, et al.European Journal of Pharmacology|June 7, 2024
Proteasome inhibitors FHND6091 enhance the ability of NK cells to kill tumor cells through multiple mechanismsAmin Liu, Tiantian Wen, Liming Ding, et al.European Journal of Medicinal Chemistry|February 22, 2023
Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myelomaXueyuan Wang, Wen Zhang, Tiantian Wen, et al.Bioorganic & Medicinal Chemistry|April 8, 2021
Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 InhibitorsYonglei Zhang, Xiaomin Xie, Xueyuan Wang, et al.Sensors (Basel, Switzerland)|April 3, 2021
An Evaluation of Executive Control Function and Its Relationship with Driving PerformanceLirong Yan, Tiantian Wen, Jiawen Zhang, et al.Journal of Medicinal Chemistry|June 25, 2025
Design and Discovery of Novel Selective RET Inhibitors with High Central Nervous System Penetration, Enhanced Pharmacokinetics, and PharmacodynamicsXueyuan Wang, Hang Miao, Xinran Ye, et al.Journal of the American Chemical Society|March 30, 2026
Programming Charge Dynamics in Photocatalytic Covalent Organic Frameworks through Heterometallic Symmetry BreakingTiantian Wen, Xiaohui Liu, Jingru Feng, et al.Drug Design, Development and Therapy|September 20, 2022
Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome InhibitorXu Yang, Amin Liu, Lin Yang, et al.Pageof 2